Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12577231 | Androgen receptor PROTACS | 🖼🧊📄§ | 2026-03-17 | 2045-06-30 | 0 | 31 |
| 12576042 | Methods and compositions for treating neurological conditions | 🖼🧊📄§ | 2026-03-17 | 2042-12-02 | 0 | 31 |
| 12576098 | Saponin containing extracts prepared from Hesperaloe useful in the treatment of non-human animals | 🖼🧊📄§ | 2026-03-17 | 2041-06-21 | 0 | 31 |
| 12576159 | Anti-human PD-1 antibody crystals and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2039-10-28 | 0 | 31 |
| 12576024 | Compositions comprising Propionibacterium acnes bacteriophages for treating acne | 🖼🧊📄§ | 2026-03-17 | 2044-01-16 | 0 | 31 |
| 12576141 | Albumin bound macromolecule tri-agonist activating GLP-1/GIP/glucagon receptors | 🖼🧊📄§ | 2026-03-17 | 2044-06-25 | 0 | 31 |
| 12576079 | Methods for treating cholestasis | 🖼🧊📄§ | 2026-03-17 | 2040-12-11 | 0 | 31 |
| 12576067 | Methods and compositions for treatment of mydriasis | 🖼🧊📄§ | 2026-03-17 | 2045-01-17 | 0 | 31 |
| 12576106 | Compositions of nitrates and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2044-05-09 | 0 | 31 |
| 12576069 | Compositions and methods for treating slow-flow vascular malformations | 🖼🧊📄§ | 2026-03-17 | 2040-09-10 | 0 | 31 |
| 12576081 | Methods and compositions for improving exercise performance, single ventricular performance, cardiac output and myocardial performance index (MPI) in single ventricular heart disease, using udenafil compositions | 🖼🧊📄§ | 2026-03-17 | 2040-07-24 | 0 | 31 |
| 12577272 | CD73 inhibitors | 🖼🧊📄§ | 2026-03-17 | 2040-10-29 | 0 | 31 |
| 12577298 | Anti-IL-5 antibodies | 🖼🧊📄§ | 2026-03-17 | 2041-07-26 | 0 | 31 |
| 12576073 | Antiarrhythmic formulation | 🖼🧊📄§ | 2026-03-17 | 2042-01-13 | 0 | 31 |
| 12577320 | Anti-Claudin 18.2 antibody and antibody-drug conjugate thereof | 🖼🧊📄§ | 2026-03-17 | 2042-05-07 | 0 | 31 |
| 12577313 | Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2042-03-01 | 0 | 31 |
| 12576037 | Polymer-encapsulated drug particles | 🖼🧊📄§ | 2026-03-17 | 2041-02-19 | 0 | 31 |
| 12576052 | Metformin inhalation powder aerosol for treating idiopathic pulmonary fibrosis and preparation method thereof | 🖼🧊📄§ | 2026-03-17 | 2043-07-28 | 0 | 31 |
| 12570757 | Antibodies against the poliovirus receptor (PVR) and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-10-07 | 0 | 31 |
| 12570958 | Single- and multi-chain chimeric antigen receptors | 🖼🧊📄§ | 2026-03-10 | 2038-12-19 | 0 | 31 |
| 12570975 | Composition for diagnosis or treatment of a condition associated with increased activity of EIF4E comprising an EIF4E inhibitor | 🖼🧊📄§ | 2026-03-10 | 2040-09-03 | 0 | 31 |
| 12570617 | Use of triazole compound as ghrelin receptor agonist | 🖼🧊📄§ | 2026-03-10 | 2041-09-17 | 0 | 31 |
| 12571046 | Methods of detecting and treating multiple system atrophy | 🖼🧊📄§ | 2026-03-10 | 2041-05-28 | 0 | 31 |
| 12570762 | Conjugate or fusion protein for cancer therapy | 🖼🧊📄§ | 2026-03-10 | 2042-09-07 | 0 | 31 |
| 12570763 | Aerosolized mucus-tethering nanobodies to protect against viral and microbial contamination in closed and semi-enclosed spaces | 🖼🧊📄§ | 2026-03-10 | 2041-05-27 | 0 | 31 |
| 12570720 | Engineered receptors for human cytomegalovirus and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-15 | 0 | 31 |
| 12570643 | 3-aryloxy-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-05-14 | 0 | 31 |
| 12570607 | Compound as cyclin-dependent kinase 9 inhibitor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-12-09 | 0 | 31 |
| 12570740 | Treatment for physiological iron overload with an anti-matriptase-2 antibody | 🖼🧊📄§ | 2026-03-10 | 2040-11-27 | 0 | 31 |
| 12570695 | Bicyclic peptide ligands specific for EphA2 | 🖼🧊📄§ | 2026-03-10 | 2040-07-30 | 0 | 31 |
| 12570704 | Functionally modified maytansinoids and compositions and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-11-05 | 0 | 31 |
| 12570713 | High-affinity TCR for recognizing AFP antigen | 🖼🧊📄§ | 2026-03-10 | 2040-03-06 | 0 | 31 |
| 12570674 | Boron carrying agent for integrated tumor diagnosis and treatment, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-03-01 | 0 | 31 |
| 12570725 | ZIKA antibodies and their use | 🖼🧊📄§ | 2026-03-10 | 2040-09-11 | 0 | 31 |
| 12569478 | Sequestration compounds for treatment of substance use disorder and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-02-10 | 0 | 31 |
| 12570661 | Isoform-specific aldehyde dehydrogenase inhibitors | 🖼🧊📄§ | 2026-03-10 | 2041-06-16 | 0 | 31 |
| 12570718 | PD-1-CD28 fusion proteins and their use in medicine | 🖼🧊📄§ | 2026-03-10 | 2041-10-29 | 0 | 31 |
| 12570697 | Cyclic peptide useful in the treatment of cancer | 🖼🧊📄§ | 2026-03-10 | 2040-03-25 | 0 | 31 |
| 12570667 | Compounds with antibacterial and anti viral activities | 🖼🧊📄§ | 2026-03-10 | 2041-08-16 | 0 | 31 |
| 12570650 | 6-substituted pyridazine compounds as SMARCA2 and/or SMARCA4 degraders | 🖼🧊📄§ | 2026-03-10 | 2041-08-03 | 0 | 31 |
| 12569438 | Nanomaterials containing constrained lipids and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-07-24 | 0 | 31 |
| 12569509 | Method and composition for preventing and treating viral infections | 🖼🧊📄§ | 2026-03-10 | 2042-04-26 | 0 | 31 |
| 12569516 | Subject-specific tumor inhibiting cells and the use thereof | 🖼🧊📄§ | 2026-03-10 | 2043-08-17 | 0 | 31 |
| 12569522 | Pharmaceutical composition comprising Sutterella wadsworthensis and immune checkpoint inhibitors for treatment of colon cancer | 🖼🧊📄§ | 2026-03-10 | 2045-06-04 | 0 | 31 |
| 12569460 | Application of thyroid hormones and thyroid hormone analogues to preparation of drugs for treating sickle-cell disease | 🖼🧊📄§ | 2026-03-10 | 2042-10-14 | 0 | 31 |
| 12569508 | Antimicrobial compositions and methods of use | 🖼🧊📄§ | 2026-03-10 | 2041-10-13 | 0 | 31 |
| 12569451 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2039-10-17 | 0 | 31 |
| 12569497 | Use of HCN inhibitors for treatment of cancer | 🖼🧊📄§ | 2026-03-10 | 2038-04-25 | 0 | 31 |
| 12569453 | Use of tapinarof for the treatment of atopic dermatitis | 🖼🧊📄§ | 2026-03-10 | 2043-02-02 | 0 | 31 |
| 12569465 | Method for activating follicles by means of using small-molecule compound, and preparation thereof | 🖼🧊📄§ | 2026-03-10 | 2041-07-08 | 0 | 31 |